Zhifeng Qi Selected Research

Zhifeng Qi Research Topics

Disease

19	Ischemic Stroke 05/2024 - 01/2013
17	Brain Ischemia (Cerebral Ischemia) 02/2024 - 04/2014
15	Ischemia 02/2024 - 12/2007
9	Stroke (Strokes) 01/2024 - 04/2014
7	Hyperoxia 05/2024 - 01/2013
7	Brain Injuries (Brain Injury) 02/2024 - 01/2013
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2023 - 04/2014
4	Inflammation (Inflammations) 02/2024 - 01/2019
4	Edema (Dropsy) 09/2023 - 05/2015
3	Hypoxia (Hypoxemia) 10/2022 - 12/2007
3	Hemorrhage 01/2021 - 01/2019
3	Cerebral Infarction 12/2020 - 04/2014
3	Infarction (Infarctions) 03/2015 - 04/2014
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2023 - 10/2018
2	Reperfusion Injury 01/2023 - 01/2015
1	Neuroinflammatory Diseases 02/2024
1	Pathologic Processes 10/2023
1	Brain Diseases (Brain Disorder) 01/2019
1	Cerebral Hemorrhage 10/2017
1	Brain Edema (Cerebral Edema) 01/2015
1	Hypothermia 04/2014
1	Necrosis 01/2013

Drug/Important Bio-Agent (IBA)

10	ZincIBA 02/2024 - 04/2014
6	Oxygen (Dioxygen)IBA 05/2024 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2017
6	OccludinIBA 01/2024 - 10/2017
4	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 01/2023 - 04/2014
4	Chelating AgentsIBA 01/2023 - 10/2015
3	Neuroprotective AgentsIBA 05/2024 - 10/2022
3	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2015
3	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2018 - 05/2015
2	Tight Junction ProteinsIBA 10/2023 - 10/2017
2	Matrix Metalloproteinases (MMPs)IBA 10/2023 - 01/2015
2	Cytochromes c (Cytochrome c)IBA 10/2022 - 10/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2018
2	Evans Blue (Blue, Evans)FDA Link 11/2016 - 05/2015
2	Erythropoietin FDA Link 03/2015 - 01/2015
1	zinc-binding protein (zinc binding protein)IBA 10/2023
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2023
1	Coloring Agents (Dyes)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 10/2022
1	Oxidoreductases (Dehydrogenase)IBA 10/2022
1	ferrostatin-1IBA 10/2022
1	Connexin 43 (Connexin43)IBA 10/2022
1	ConnexinsIBA 10/2022
1	NADPH Oxidase 4IBA 10/2022
1	Protein Kinase CIBA 07/2020
1	Mitogen-Activated Protein KinasesIBA 07/2020
1	NF-kappa B (NF-kB)IBA 07/2020
1	Peptides (Polypeptides)IBA 07/2020
1	Hormones (Hormone)IBA 07/2020
1	SteroidsIBA 07/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	Claudin-5IBA 10/2017
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 11/2016
1	IonsIBA 11/2016
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 06/2015
1	Beclin-1IBA 06/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2015
1	salubrinalIBA 03/2015
1	isothiocyanic acidIBA 03/2015
1	hydroxysafflor yellow AIBA 08/2014
1	Poly (ADP-Ribose) Polymerase-1IBA 04/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2014
1	GasesIBA 04/2014
1	p38 Mitogen-Activated Protein KinasesIBA 12/2007

Therapy/Procedure

10	Therapeutics 05/2024 - 01/2013
3	Thrombectomy 01/2021 - 10/2018
1	Duration of Therapy 05/2024
1	Sutures (Suture) 10/2022
1	Stents 01/2020
1	Subcutaneous Injections 03/2015
1	Intra-Arterial Infusions 03/2015
1	Intravenous Administration 08/2014
1	Thrombolytic Therapy 04/2014
1	Laser Therapy (Surgery, Laser) 04/2014
1	Drug Therapy (Chemotherapy) 04/2014